⚠ Evidence warning: Clinical trials or other evidence do not support the claim that daily fennel decoction maintains sight and slows diabetic cataract, and that a fennel-seed eye wash relieves dry eye and conjunctivitis. This page keeps it as a report of what people, websites or other media say.
Fennel for Eye Health
The fennel-for-vision tradition stretches back at least to the Roman naturalist Pliny the Elder, who in the first century CE listed fennel among the herbs serpents use to restore their sight after molting — an origin story for the long-running European folk practice of using fennel-seed decoction as an eye wash and as a daily drink to maintain "sharp sight." Greek physicians, the Ayurvedic tradition (which calls fennel saunf and prescribes it as a daily morning drink for "clear vision into old age"), and the medieval European herbalists (Culpeper, Hildegard von Bingen) all converged on the same use. The honest scientific assessment in 2026 is more measured: there is a 2008 rabbit study by Agarwal and colleagues in which fennel-seed extract eye drops lowered eye pressure in experimental models of glaucoma, laboratory data showing that trans-anethole from fennel blocks the aldose-reductase enzyme and protected lens tissue kept in high-sugar fluid, the documented systemic antioxidant activity of the fennel flavonoids quercetin and kaempferol reaching the aqueous humor, and the strong tradition — but no large human randomized trials. This deep-dive walks through what is known, what is hypothesized, what is folkloric, and how fennel has traditionally been used for eye-health support.
Table of Contents
- Pliny's Serpents and the Roman Tradition of Fennel for Sight
- The Indian Ayurvedic Tradition of Daily Fennel for Vision
- The Agarwal 2008 Rabbit Study of Fennel Eye Drops and Eye Pressure
- The Aldose-Reductase Modulation Hypothesis
- Quercetin, Kaempferol, and Systemic Antioxidant Reach to the Eye
- Flavonoid-Rich Foods and Macular Degeneration in the Blue Mountains Eye Study
- Diabetic Cataract and the Sorbitol Pathway
- Dry Eye, Conjunctivitis, and the Eye-Wash Use
- Age-Related Macular Degeneration — What Fennel Does and Does Not Address
- Honest Framing — Where Fennel Sits in the Eye-Health Evidence Hierarchy
- Traditional Ways Fennel Is Taken for Eye Health
- Key Research Papers
- Connections
- Featured Videos
Pliny's Serpents and the Roman Tradition of Fennel for Sight
In Book 8 of his Natural History (completed around 77 CE), the Roman naturalist Pliny the Elder described the post-molting behavior of serpents: "Snakes are said to feast upon the juice of fennel as a way of recovering their lost sight after winter sleep." The observation is empirically wrong (snakes do not actually eat fennel for any documented reason), but as a piece of cultural anthropology it is informative: by the first century CE, fennel was already so strongly associated with vision in the popular imagination that Pliny's readers would have found the story plausible.
The Roman medical tradition that grew out of this association recommended:
- Daily fennel-seed decoction taken internally to maintain visual acuity into old age
- A diluted fennel-seed eye wash for tired or inflamed eyes (the equivalent of modern over-the-counter eye drops)
- Fennel-bulb consumption as a daily vegetable to support eye nutrition
- Fennel-honey lozenges as a slow-absorption form of the same active compounds
The Roman tradition was inherited by the medieval European herbalists. Hildegard von Bingen (1098-1179) wrote about fennel as preserving clear sight in her Physica. Nicholas Culpeper's seventeenth-century English herbal continued the same recommendation. The empirical observation underneath the tradition was likely a combination of: (a) older monks and laypeople who chronically consumed fennel-containing drinks reported subjectively better vision into old age, (b) the diluted fennel-water eye wash had immediate soothing effect on inflamed eyes (which is true — the warm-water rinse plus mild anti-inflammatory compounds in the decoction has the same mechanism as modern artificial tears), and (c) the broader association of fennel with the all-purpose "herb of long life" in pre-scientific traditional medicine.
The Indian Ayurvedic Tradition of Daily Fennel for Vision
Independently of the Roman tradition, the Indian Ayurvedic tradition arrived at the same use of fennel for eye health. In Ayurveda, fennel (saunf) is classified as a tridoshic herb — one that balances all three constitutional types (vata, pitta, and kapha) — and is one of the few herbs prescribed indiscriminately to all patients regardless of constitution. The eye-health indication appears in several canonical Ayurvedic texts:
- Charaka Samhita (compiled approximately 100 BCE, the foundational Ayurvedic text) — lists fennel among the herbs that "clear the eyes and the mind"
- Sushruta Samhita (the surgical text of Ayurveda) — recommends fennel-seed decoction as part of the preoperative and postoperative regimen for cataract surgery (which Sushruta describes — the "couching" procedure of pushing the opacified lens out of the visual axis was performed in India well over 2,000 years ago)
- Astanga Hridaya — describes fennel for "netra roga" (general eye disease) as a daily preventive
The contemporary Ayurvedic practice that has descended from these texts:
- Daily morning empty-stomach fennel decoction (the cold-infusion protocol described on the digestive aid page) is recommended for daily eye-health maintenance, particularly in older adults
- The fennel-sugar mix called mukhwas, eaten after meals, is partially attributed to eye-health benefit alongside its more obvious digestive role
- A specific Ayurvedic preparation called triphala (a combination of three myrobalan fruits) is the primary Ayurvedic eye herb, and is often combined with fennel decoction in formal eye-health regimens
- Topical use of cooled fennel decoction as a gentle eye-wash is recommended for irritated or strained eyes
The longevity-with-clear-vision claim attached to traditional Indian fennel use is anecdotally striking — Indian monastic traditions describe elderly monks in their nineties continuing to read sacred texts by oil-lamp without visible visual impairment, and credit the daily fennel decoction. The empirical basis for this anecdote has never been formally tested, but it is consistent with the general life-expectancy advantage of plant-rich Mediterranean-style diets and is not implausible.
The Agarwal 2008 Rabbit Study of Fennel Eye Drops and Eye Pressure
The main modern animal study of fennel applied to the eye is Agarwal R, Gupta SK, Agrawal SS, Srivastava S, Saxena R (2008), titled "Oculohypotensive effects of Foeniculum vulgare in experimental models of glaucoma". It is a glaucoma (eye-pressure) study in rabbits, not a cataract study. It tested a single drop of an aqueous extract of fennel seed:
- Animal model: rabbits with normal intraocular pressure (IOP, the fluid pressure inside the eye) and rabbits with experimentally raised eye pressure
- Raised-pressure models: water loading (an acute model) and steroid-induced glaucoma (a chronic model)
- Intervention: a single drop of aqueous fennel-seed extract at 0.3%, 0.6% and 1.2% (w/v); the 0.6% strength was carried into the glaucoma models
- Comparison: vehicle-treated eyes; the authors compared the effect with timolol, a standard glaucoma eye drop
Key findings:
- In rabbits with normal eye pressure, the extract lowered intraocular pressure by 17.49%, 21.16% and 22.03% at the 0.3%, 0.6% and 1.2% strengths
- In the water-loading model, the maximum mean difference between vehicle-treated and extract-treated eyes was 31.20%
- In the steroid-induced glaucoma model, the maximum mean lowering of eye pressure was 31.29%
- The authors described the effect as comparable to that of timolol
The authors wrote that further investigation into the mechanism of action, possible toxicity and human clinical trials are warranted before fennel could find a place among glaucoma drugs. This rabbit study did not examine cataract; its findings concern eye pressure only.
The Aldose-Reductase Modulation Hypothesis
One specific mechanism by which fennel may protect against cataract formation is through modulation of the aldose-reductase enzyme, which is central to the pathogenesis of diabetic cataract and is also relevant to age-related cataract.
The mechanism in brief:
- The lens is a metabolically isolated structure with very high glucose concentration in its surrounding aqueous humor (especially in diabetes)
- Aldose reductase converts excess glucose to sorbitol within lens fiber cells
- Sorbitol cannot easily diffuse out of lens cells because of its polar character
- Accumulated intracellular sorbitol creates osmotic stress, drawing water into the lens cell
- The osmotic swelling damages lens fiber cell membranes and proteins, producing opacification (cataract)
- Aldose-reductase inhibitors (the experimental drug class including epalrestat, ranirestat, and zopolrestat) slow this pathway and have been explored as diabetic-cataract preventives
In a 2012 laboratory study (Dongare and colleagues), researchers split fennel fruit into fractions and tested each one (bioguided fractionation). They identified trans-anethole as the part with potent aldose-reductase inhibitory action, with an IC50 (the concentration that blocks half of the enzyme's activity) of 3.8 μg/ml; it showed a noncompetitive to mixed type of inhibition of lens aldose reductase. In eye lenses kept in high-sugar (55 mM glucose) fluid in the laboratory, trans-anethole raised soluble lens protein, reduced glutathione, and catalase and superoxide dismutase (SOD) activity — an anti-cataract action in vitro. In streptozotocin-induced diabetic rats, prolonged treatment with one fennel fraction (the pet ether fraction of the distillate) improved blood glucose, lipid profile and glycated haemoglobin. The lens work was done in the laboratory, not in animals or people, and whether drinking fennel tea delivers enough anethole to the human lens is not known.
This is a plausible mechanism for slowing the progression of diabetic cataract, age-related cortical cataract, and the cataract component of metabolic syndrome. The mechanism has not been tested in human diabetic-cataract trials; the support so far is the laboratory lens work.
If the mechanism holds in people, it would matter most for people with diabetes or pre-diabetes who are at elevated cataract risk — precisely the population in which the aldose-reductase pathway is most active.
Quercetin, Kaempferol, and Systemic Antioxidant Reach to the Eye
Beyond the anethole-aldose-reductase hypothesis, fennel contains substantial amounts of the flavonoids quercetin and kaempferol, both of which are systemic antioxidants with documented bioavailability after oral consumption and documented reach to the aqueous humor of the eye.
The relevant points about flavonoid antioxidant reach to the eye:
- Quercetin and kaempferol from dietary sources show measurable plasma concentrations 1-4 hours after consumption
- Pharmacokinetic studies have detected both compounds in the aqueous humor and vitreous after oral administration
- In the eye, these flavonoids scavenge reactive oxygen species (ROS) that would otherwise damage lens crystallins, retinal pigment epithelium, and photoreceptor outer segments
- The same flavonoids have demonstrated retinal protective effects in animal models of light-induced retinal degeneration and ischemia-reperfusion injury
This is the general mechanism proposed for the link between plant-rich diets and eye health in epidemiological data (in the Blue Mountains Eye Study (BMES), an Australian cohort, higher flavonol and flavanone intake was linked with lower odds of age-related macular degeneration (AMD); see the next section). Fennel contributes to that flavonoid intake but is not unique in doing so — turmeric, kale, blueberries, green tea, and onions are all richer per-gram sources of quercetin and kaempferol.
The honest framing is that fennel's flavonoid contribution to eye health is real but unspectacular — one node in a broader pattern of dietary antioxidants. For the patient who is concerned about eye health, fennel is one element in a portfolio of dietary interventions, not the central one. The measures most often discussed are: a flavonoid-rich plant-based diet broadly; fish, a source of retinal docosahexaenoic acid (DHA) (in the Nurses' Health Study and Health Professionals Follow-up Study, more than 4 servings of fish a week was associated with a 35% lower risk of age-related macular degeneration than 3 or fewer servings a month, while omega-3 supplements added to the Age-Related Eye Disease Study (AREDS) formula did not reduce progression in the Age-Related Eye Disease Study 2 (AREDS2)); lutein and zeaxanthin from dark leafy greens; ultraviolet-blocking sunglasses; and (for age-related macular degeneration) the AREDS-type supplement formula.
Flavonoid-Rich Foods and Macular Degeneration in the Blue Mountains Eye Study
The Blue Mountains Eye Study is a population-based Australian cohort. In a 2018 analysis, 2,856 adults aged 49 and over were included in the prevalence analysis and 2,037 who were followed up 15 years later in the incidence analysis; diet was measured with a food-frequency questionnaire and macular degeneration from retinal photographs. Each 1-standard-deviation increase in total flavonol and total flavanone intake was associated with reduced odds of having any age-related macular degeneration (odds ratios 0.75 and 0.77). People who reported at least one serving of oranges a day had a reduced risk of late age-related macular degeneration 15 years later compared with people who never ate oranges (odds ratio 0.39). The authors called the study exploratory and wrote that additional prospective cohort studies are needed. The study looked at flavonoid-rich foods in general, not at fennel.
Diabetic Cataract and the Sorbitol Pathway
Diabetic cataract is a special case of cataract formation in which fennel's aldose-reductase mechanism is most directly relevant. The cataract experienced by patients with diabetes (especially uncontrolled diabetes, especially type 1 diabetes with long duration) develops 10-15 years earlier than age-related cataract on average and progresses more rapidly. The dominant mechanism is the sorbitol osmotic pathway described above, plus a contribution from non-enzymatic glycation of lens crystallins.
The interventions that slow diabetic cataract progression:
- Glycemic control — the single most important intervention; intensive blood-sugar control measurably slows diabetic cataract development
- Aldose-reductase inhibitor drugs — experimental class; epalrestat is approved in Japan for diabetic neuropathy but not in the US or Europe
- Antioxidant nutrition — vitamin C, vitamin E, lutein, and the broader flavonoid intake have shown modest benefit in observational data
- Surgical cataract extraction with intraocular lens implantation — the definitive treatment once the cataract becomes visually significant
Fennel fits in the "antioxidant nutrition" bucket and, in laboratory work, also shows the aldose-reductase mechanism. Ayurvedic and European herbal traditions describe daily fennel decoction (either the Ayurvedic empty-stomach morning preparation or 1-2 cups of fennel tea per day) as a dietary addition alongside glycemic control and the other antioxidant-nutrition measures. Its effect on diabetic cataract in people has not been measured; fennel tea is an inexpensive, food-level preparation.
See our Type 2 Diabetes page for the broader management framework that fennel would complement, not substitute for.
Dry Eye, Conjunctivitis, and the Eye-Wash Use
The traditional use of cooled fennel-seed decoction as a topical eye wash is the eye-health use people most often describe as giving immediate, noticeable relief. The proposed mechanism:
- The warm-water rinse mechanically clears debris, allergens, and irritants from the ocular surface
- The mild anti-inflammatory compounds in the decoction (anethole, quercetin, kaempferol) reduce conjunctival inflammation
- The mild antimicrobial activity of fennel essential oil may reduce surface bacterial load in mild bacterial conjunctivitis
- The slight osmotic activity of the decoction helps reduce conjunctival edema
For mild conjunctival irritation (dry-eye flare, mild seasonal allergic conjunctivitis, environmental irritant exposure), people who use a fennel-seed eye wash describe noticeable symptom relief. The traditional preparation:
- 1 teaspoon of fennel seed in 250 mL of distilled or boiled-and-cooled water
- Steeped 10-15 minutes, then strained very carefully through a fine cloth or coffee filter
- Cooled to room or slightly-warmer-than-body temperature
- Applied with sterile cotton balls (soaked, then wrung over the closed eye) or with a sterilized eye-cup
- Used within 24 hours of preparation; any unused solution is discarded
Important safety notes for the eye-wash use:
- Raw tap water can introduce Acanthamoeba and other pathogenic organisms into the eye; the traditional preparation uses distilled or properly boiled-and-cooled water
- Particles of fennel seed left in the liquid can cause significant corneal abrasion (a scratched cornea)
- The fennel-water eye wash is a traditional remedy for mild irritation, not a treatment for frank infection — pus, severe pain, photophobia (light sensitivity) or vision change are signs that eye doctors treat as urgent
- For contact-lens wearers, the described practice is to remove the lenses before the eye wash and wait at least 2 hours before reinserting them
- Irritation that worsens after an eye wash is a sign the eye is reacting to it
Age-Related Macular Degeneration — What Fennel Does and Does Not Address
Age-related macular degeneration (AMD) is the leading cause of irreversible vision loss in adults over 60 in the developed world. The condition exists in two main forms: dry age-related macular degeneration (gradual atrophy of the macular retinal pigment epithelium and photoreceptors, accumulation of drusen) and wet age-related macular degeneration (neovascular age-related macular degeneration, abnormal blood vessel growth from the choroid into the retina with subsequent hemorrhage and fibrosis).
The interventions tested for age-related macular degeneration:
- For wet age-related macular degeneration: anti-vascular endothelial growth factor (anti-VEGF) intravitreal injections (ranibizumab, aflibercept, faricimab, brolucizumab) — the standard of care, with dramatic visual outcomes vs untreated disease
- For dry age-related macular degeneration: in the original AREDS trial (3,640 participants aged 55-80, average follow-up 6.3 years), a daily supplement of vitamin C 500 mg, vitamin E 400 international units (IU), beta carotene 15 mg, zinc 80 mg (as zinc oxide) and copper 2 mg reduced the odds of developing advanced age-related macular degeneration compared with placebo (odds ratio 0.72; 99% confidence interval 0.52-0.98). AREDS2 then found no apparent effect of eliminating beta carotene or lowering the zinc dose on progression to advanced disease; because more lung cancers occurred in the beta carotene group than in the no-beta-carotene group (23 [2.0%] vs 11 [0.9%]), mostly in former smokers, the AREDS2 authors concluded that lutein (10 mg) + zeaxanthin (2 mg) could be an appropriate carotenoid substitute in the AREDS formula
- For both: smoking cessation, ultraviolet (UV) protection, and a Mediterranean diet; omega-3 supplements (DHA + eicosapentaenoic acid (EPA)) added to the AREDS formula did not reduce progression to advanced age-related macular degeneration in AREDS2 (hazard ratio 0.97; P = .70)
AREDS2 (4,203 participants aged 50 to 85, median follow-up 5 years) also found that adding lutein + zeaxanthin, DHA + EPA, or both to the AREDS formula did not further reduce progression to advanced age-related macular degeneration in the primary analyses: the 5-year probability of progression was 31% on placebo, 29% on lutein + zeaxanthin, 31% on DHA + EPA, and 30% on both.
Where does fennel fit? Honestly — fennel does not have a defined role in age-related macular degeneration treatment or prevention. The flavonoid antioxidant mechanism is generally consistent with Mediterranean-diet eye protection, and the quercetin/kaempferol content contributes to broad-spectrum antioxidant intake, but fennel is not in any age-related macular degeneration treatment guideline and has not been tested as a replacement for the AREDS-type supplement in people with intermediate or advanced age-related macular degeneration.
In short: the AREDS-type supplement has trial evidence in documented intermediate or advanced age-related macular degeneration; lutein and zeaxanthin come from kale, spinach, collards and egg yolks in a Mediterranean-style diet; and daily fennel decoction is, in traditional use, one piece of a broad antioxidant-rich diet — not an age-related macular degeneration-specific intervention.
Honest Framing — Where Fennel Sits in the Eye-Health Evidence Hierarchy
It is worth stating directly: among the four fennel deep-dive applications on this site, eye health has the weakest formal randomized clinical evidence. The other three (digestive aid, lactation, menstrual / menopausal) each have multiple modern randomized clinical trials in humans. Eye health rests primarily on traditional use, an animal study of eye pressure (the Agarwal 2008 rabbit study), laboratory lens data (Dongare 2012), plausible mechanisms (aldose-reductase modulation, flavonoid antioxidant reach to the eye), and broad consistency with the dietary-antioxidant epidemiology of cataract and age-related macular degeneration — but no large definitive randomized human trial.
This does not mean the eye-health application is wrong — the evidence pattern (multiple traditional cultures, plausible mechanism, an animal eye-pressure study, consistent in vitro mechanism studies) is exactly what one would expect for a real but modest effect that simply has not been the subject of a definitive trial. It does mean that fennel for eye health is a supplementary practice rather than a primary intervention; for significant eye disease (advanced cataract, diabetic retinopathy, age-related macular degeneration, glaucoma), the treatments with trial evidence are the medical and surgical ones listed below, and fennel has been studied only as a food, not as a replacement for them.
The evidence-hierarchy verdict:
- Strong evidence in fennel deep dives: digestive aid (Alexandrovich infant colic), menstrual / menopausal (Omidvar dysmenorrhea, Rahimikian menopause)
- Moderate evidence: lactation / galactagogue (Sim review and Turkmen trial)
- Encouraging but preliminary evidence: eye health (Agarwal rabbit eye-pressure study + laboratory lens data + tradition; awaiting human randomized controlled trials (RCTs))
Traditional Ways Fennel Is Taken for Eye Health
The ways fennel is traditionally taken for eye-health support:
- Daily fennel decoction (Ayurvedic morning protocol) — 1 tablespoon of crushed fennel seed soaked overnight in 300-400 mL room-temperature water, drunk on empty stomach in the morning. Traditionally credited with delivering fennel's flavonoids and anethole; this is the approach with the longest traditional pedigree.
- Daily fennel tea (European protocol) — 1-2 cups of fennel-seed tea per day (1 teaspoon crushed seed per cup, steeped 10 minutes). Simpler to prepare; lower dose than the Ayurvedic cold infusion.
- Diet-integrated fennel — the fennel bulb eaten regularly as a raw vegetable or roasted side dish, the fennel-frond garnish on salads and fish dishes, and the post-meal seed chew. This is the Mediterranean approach — spread fennel exposure across multiple food preparations without a designated "medicinal" dose form.
- Fennel eye wash (occasional symptomatic use) — for episodes of mild eye irritation, dry-eye flare, or environmental allergen exposure. See the dry-eye section for preparation details and safety notes.
Eye care with trial or guideline support, which fennel has not been tested against or as a replacement for:
- Annual comprehensive eye exam in adults over 40, more frequent in patients with diabetes, glaucoma family history, or high myopia
- Anti-VEGF treatment for neovascular age-related macular degeneration (sight-saving)
- The AREDS2 supplement for intermediate or advanced dry age-related macular degeneration
- Cataract surgery when the cataract becomes visually significant
- IOP-lowering treatment for glaucoma
- Glycemic control in diabetic retinopathy
- Ultraviolet protection (sunglasses) and smoking cessation
Fennel is a piece of a broader eye-health portfolio, not a primary treatment for any defined ophthalmological condition.
Key Research Papers
- Agarwal R, Gupta SK, Agrawal SS, Srivastava S, Saxena R (2008). Oculohypotensive effects of Foeniculum vulgare in experimental models of glaucoma. Indian Journal of Physiology and Pharmacology. 52(1):77-83. — PubMed PMID: 18831355
- Dongare V, Kulkarni C, Kondawar M, Magdum C, Haldavnekar V, Arvindekar A (2012). Inhibition of aldose reductase and anti-cataract action of trans-anethole isolated from Foeniculum vulgare Mill. fruits. Food Chemistry. — PubMed PMID: 26434305
- Choi EM, Hwang JK (2004). Anti-inflammatory, analgesic and antioxidant activities of the fruit of Foeniculum vulgare. Fitoterapia. — PubMed
- Boskabady MH, Khatami A, Nazari A (2004). Possible mechanism(s) for relaxant effects of Foeniculum vulgare on guinea pig tracheal chains. Pharmazie. 59(7):561-4. — PubMed PMID: 15296096
- Diao WR et al. (2014). Chemical composition, antibacterial activity and mechanism of action of essential oil from seeds of fennel (Foeniculum vulgare). Food Control. — PubMed
- Boots AW, Haenen GR, Bast A (2008). Health effects of quercetin: from antioxidant to nutraceutical. European Journal of Pharmacology. — PubMed PMID: 18417116
- Calderon-Montano JM et al. (2011). A review on the dietary flavonoid kaempferol. Mini-Reviews in Medicinal Chemistry. — PubMed PMID: 21428901
- Age-Related Eye Disease Study 2 Research Group (2013). Lutein + zeaxanthin and omega-3 fatty acids for age-related macular degeneration: the Age-Related Eye Disease Study 2 (AREDS2) randomized clinical trial. JAMA. 309(19):2005-15. — PubMed PMID: 23644932
- Age-Related Eye Disease Study Research Group (2001). A randomized, placebo-controlled, clinical trial of high-dose supplementation with vitamins C and E, beta carotene, and zinc for age-related macular degeneration and vision loss: AREDS report no. 8. Archives of Ophthalmology. 119(10):1417-36. — PubMed PMID: 11594942
- Pollreisz A, Schmidt-Erfurth U (2010). Diabetic cataract — pathogenesis, epidemiology and treatment. Journal of Ophthalmology. — PubMed PMID: 20634936
- Kinoshita JH (1974). Mechanisms initiating cataract formation. Proctor lecture. Investigative Ophthalmology. — PubMed: Kinoshita aldose-reductase
- Cho E, Hung S, Willett WC, et al. (2001). Prospective study of dietary fat and the risk of age-related macular degeneration. American Journal of Clinical Nutrition. 73(2):209-18. — PubMed PMID: 11157315
- Gopinath B, Liew G, Kifley A, et al. (2018). Dietary flavonoids and the prevalence and 15-y incidence of age-related macular degeneration. American Journal of Clinical Nutrition. 108(2):381-387. — PubMed PMID: 29982448
PubMed Topic Searches
Connections
- All Herbs
- Fennel Overview
- Fennel Benefits Hub
- Fennel as Digestive Aid
- Fennel for Lactation
- Fennel for Menstrual & Menopausal
- Vitamin A (Vision)
- Vitamin A for Vision & Eye Health
- Vitamin C (Eye Antioxidant)
- Vitamin E (Lens Antioxidant)
- Turmeric (Curcumin)
- Kale (Lutein / Zeaxanthin)
- Omega-3 Fatty Acids (Retinal Docosahexaenoic Acid)
- Zinc (AREDS Formula)
- Type 2 Diabetes
- History